Healthcare provider profile · identity verified

Sharad C. Arora, MD

Internal Medicine · STOCKTON, CA · NPI 1124106026

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	667	264
Lisinopril	Lisinopril	357	144
Amlodipine Besylate	Amlodipine Besylate	337	142
Levothyroxine Sodium	Levothyroxine Sodium	306	107
Losartan Potassium	Losartan Potassium	276	108
Fluticasone Propionate	Fluticasone Propionate	256	100
Famotidine	Famotidine	221	89
Tamsulosin Hcl	Tamsulosin Hcl	190	77
Atenolol	Atenolol	167	63
Albuterol Sulfate Hfa	Albuterol Sulfate	154	82
Tizanidine Hcl	Tizanidine Hcl	152	38
Ibuprofen	Ibuprofen	141	46
Pantoprazole Sodium	Pantoprazole Sodium	140	55
Hydrochlorothiazide	Hydrochlorothiazide	137	59
Ozempic	Semaglutide	129	27
Metformin Hcl	Metformin Hcl	127	49
Gabapentin	Gabapentin	126	61
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	125	33
Metoprolol Succinate	Metoprolol Succinate	124	50
Metformin Hcl Er	Metformin Hcl	119	56
Metoprolol Tartrate	Metoprolol Tartrate	119	50
Jardiance	Empagliflozin	110	44
Omeprazole	Omeprazole	97	37
Alendronate Sodium	Alendronate Sodium	86	35
Alvesco	Ciclesonide	86	37
Furosemide	Furosemide	85	41
Glipizide	Glipizide	79	38
Hydralazine Hcl	Hydralazine Hcl	76	31
Allopurinol	Allopurinol	69	24
Trazodone Hcl	Trazodone Hcl	69	24
Doxycycline Monohydrate	Doxycycline Monohydrate	65	34
Sertraline Hcl	Sertraline Hcl	58	22
Lovastatin	Lovastatin	57	20
Montelukast Sodium	Montelukast Sodium	56	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	27
Finasteride	Finasteride	54	26
Pradaxa	Dabigatran Etexilate Mesylate	54	23
Baclofen	Baclofen	52	21
Carvedilol	Carvedilol	52	22
Tramadol Hcl	Tramadol Hcl	51	17
Ipratropium Bromide	Ipratropium Bromide	49	24
Meloxicam	Meloxicam	49	18
Pravastatin Sodium	Pravastatin Sodium	48	17
Terazosin Hcl	Terazosin Hcl	48	18
Potassium Chloride	Potassium Chloride	47	22
Humulin N	Insulin Nph Human Isophane	46	19
Alprazolam	Alprazolam	45	15
Amoxicillin	Amoxicillin	45	36
Fluocinonide	Fluocinonide	45	18
Venlafaxine Hcl Er	Venlafaxine Hcl	45	18
Breyna	Budesonide/Formoterol Fumarate	43	22
Clopidogrel	Clopidogrel Bisulfate	42	22
Duloxetine Hcl	Duloxetine Hcl	42	17
Simvastatin	Simvastatin	40	20
Rosuvastatin Calcium	Rosuvastatin Calcium	39	19
Sumatriptan Succinate	Sumatriptan Succinate	39	12
Wixela Inhub	Fluticasone Propion/Salmeterol	39	13
Citalopram Hbr	Citalopram Hydrobromide	38	18
Colchicine	Colchicine	33	suppressed
Morphine Sulfate Er	Morphine Sulfate	33	suppressed
Spiriva Respimat	Tiotropium Bromide	33	13
Triamcinolone Acetonide	Triamcinolone Acetonide	33	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	32	20
Ondansetron Hcl	Ondansetron Hcl	32	suppressed
Propranolol Hcl Er	Propranolol Hcl	32	suppressed
Spironolactone	Spironolactone	32	14
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	31	31
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	16
Chlorthalidone	Chlorthalidone	29	12
Nystatin	Nystatin	29	12
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	29	13
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	28	19
Nifedipine Er	Nifedipine	28	suppressed
Cephalexin	Cephalexin	27	23
Metronidazole	Metronidazole	27	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	12
Glimepiride	Glimepiride	25	suppressed
Acyclovir	Acyclovir	24	12
Hydrocortisone	Hydrocortisone	24	19
Memantine Hcl	Memantine Hcl	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Cefadroxil	Cefadroxil	23	19
Prednisone	Prednisone	23	14
Betamethasone Valerate	Betamethasone Valerate	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Lactulose	Lactulose	22	suppressed
Nabumetone	Nabumetone	22	suppressed
Naproxen	Naproxen	22	11
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Scopolamine	Scopolamine	20	11
Bisoprolol Fumarate	Bisoprolol Fumarate	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	12
Nortriptyline Hcl	Nortriptyline Hcl	19	12
Bumetanide	Bumetanide	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Temazepam	Temazepam	17	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Humulin R	Insulin Regular, Human	16	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	13
Clonazepam	Clonazepam	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Eliquis	Apixaban	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Victoza 2-Pak	Liraglutide	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Cartia Xt	Diltiazem Hcl	12	11
Eszopiclone	Eszopiclone	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Brilinta	Ticagrelor	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Estradiol	Estradiol	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Topiramate	Topiramate	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error